期刊文献+

孕酮受体在人子宫内膜基质细胞蜕膜化过程中的作用机制研究现状

Current research status of mechanism of progesterone receptor in human endometrial stroma cell deciduation
原文传递
导出
摘要 人子宫内膜基质细胞蜕膜化(hESCD),是人类胚胎植入和维持妊娠的关键环节。hESCD主要是指排卵后,子宫内膜在孕酮与孕酮受体(PGR)作用下,发生一系列生物学、形态学改变及细胞外基质重建。但是,对于孕酮-PGR信号通路在hESCD过程中的具体分子作用机制,迄今尚未阐明。笔者拟就PGR结构及其亚型,hESCD过程中孕酮-PGR信号通路的生理作用、网络调控,以及PGR水平及其功能异常与hESCD异常疾病关系4个方面的最新研究进展进行阐述。 Human endometrial stroma cell decidualization(hESCD)is a key link in embryo implantation and pregnancy maintenance.hESCD mainly means that endometrium undergoes a series of biological and morphological changes and extracellular matrix reconstruction by effects of progesterone and progesterone receptor(PGR)after ovulation.However,up to now,the specific molecular mechanism of progesterone-PGR signal pathway in hESCD has not been fully elucidated.This paper focuses on recent research status of the structure and subtypes of PGR,physiological function and regulation network of progesterone-PGR signal pathway,and relationship between abnormal PGR and abnormal diseases of hESCD.
作者 黄品秀 曾定元 Huang Pinxiu;Zeng Dingyuan(Reproductive Medicine Center,Liuzhou Maternity and Child Healthcare Hospital,Liuzhou 545001,Guangxi Zhuang Autonomous Region,China)
出处 《中华妇幼临床医学杂志(电子版)》 CAS 2022年第2期245-248,共4页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
基金 国家自然科学基金项目(82001553、82160296) 广西壮族自治区自然科学基金项目(2019JJB140179) 广西壮族自治区重点研发计划(桂科AB18126056) 柳州科技重点研发计划(2018BJ10301) 柳州市科技计划项目(2018DB20501)。
关键词 受体 孕酮 孕酮抵抗 子宫内膜异位症 子宫内膜蜕膜化 反复种植失败 胚胎植入 女(雌)性 Receptors,progesterone Progesterone resistance Endometriosis Decidualization of endometrium Repeated implantation failure Embryo implantation Female
  • 相关文献

参考文献2

二级参考文献194

  • 1孙慧清,盖凌,邴战勇,张立宏,张梅心,周家璧,许燕雪,孙洪钺.育龄期正常月经周期妇女子宫内膜雌二醇、孕酮受体含量的研究[J].生殖与避孕,1993,13(5):391-393. 被引量:5
  • 2邹继超,刘兰英,宋祥芬.兔子宫内膜细胞核雌激素受体的分析[J]动物学报,1985(01).
  • 3冯蓓,张丽珠.早孕妇女血清孕酮、雌二醇水平和蜕膜组织孕酮受体的变化及其在早孕维持中的作用[J]生殖与避孕,1984(02).
  • 4McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002; 108(4): 465-474.
  • 5Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451-486.
  • 6Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999; 20(3): 358-417.
  • 7Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 2006; 58(4): 782-797.
  • 8Bain DL, Connaghan KD, Maluf NK, Yang Q, Miura MT, De Angelis RW, Degala GD, Lambert JR. Steroid receptorDNA interactions: toward a quantitative connection between energetics and transcriptional regulation. Nucleic Acids Res 2014; 42(2): 691-700.
  • 9Nagy L, Schwabe JW. Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 2004; 29(6): 317- 324.
  • 10Cato L, Neeb A, Brown M, Cato AC. Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23and Bag-lL. Nucl Recept Signal 2014; 12: e005.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部